Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
STAT3h
The companies paying hospitals to hand over patient data to train AI
A new crop of companies is lining up to buy patient data from hospitals and sell it to those wanting to train AI or do ...
Truveta sells stakes to Regeneron, Illumina in deal to build genetic database
Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will ...
pharmaphorum3d
Regeneron, Illumina join $320m Truveta investment
The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...
STAT3d
Truveta enlists health systems, drugmakers to launch ambitious new genomic database
Health data company Truveta is partnering with health systems and drugmakers to create a massive database of genetic data ...
Regeneron announces strategic collaboration with Truveta
Regeneron Pharmaceuticals (REGN) announced a strategic collaboration with Truveta and its collective of U.S. health systems to advance ...
Regeneron Working with Truveta's Network to Extend Database
The company said Monday that it will provide a $119.5 million investment in Truveta's Series C financing round and help launch the company's Truveta Genome Project, which will extend Regeneron's ...
STAT2d
Pharmalittle: We’re reading about pharma asking Trump to pause Medicare talks, a Truveta database launch, and more
Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...